Average Co-Inventor Count = 2.56
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Auspex Pharmaceuticals, Inc. (37 from 71 patents)
2. Bayer Pharmaceuticals Corporation (11 from 70 patents)
3. Bayer Healthcare LLC (4 from 780 patents)
4. Ontogen Corporation (3 from 23 patents)
5. Bayer Intellectual Property Gmbh (2 from 721 patents)
6. Novartis Ag (1 from 3,923 patents)
7. Bayer Schering Pharma Ag (1 from 192 patents)
8. Irm LLC (1 from 151 patents)
9. National Institutes of Health, a Component of the US Dept. of Health & Human Services (3,435 patents)
59 patents:
1. 12077487 - Methods of manufacturing benzoquinoline compounds
2. 11813232 - Analogs of deutetrabenazine, their preparation and use
3. 11666566 - Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
4. 11179386 - Analogs of deutetrabenazine, their preparation and use
5. 11033540 - Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
6. 10966922 - Pharmaceutical formulations
7. 10722479 - Dimethoxyphenyl inhibitors of vesicular monoamine transporter 2
8. 10689370 - Cyclopropane carboxamide modulators of cystic fibrosis transmembrane conductance regulator
9. 10626105 - Deuterium-substituted pyridin- and pyrimidin-2-yl-methylamine compounds
10. 10568965 - Aminopyrimidine inhibitors of tyrosine kinase
11. 10513488 - Methods of manufacturing benzoquinoline compounds
12. 10167278 - Cyclopropanecarboxamide modulators of cystic fibrosis transmembrane conductance regulator
13. 10166183 - Pharmaceutical formulations
14. 9884819 - Tetrahydrocarbazole inhibitors of SIRT1 receptors
15. 9856261 - Piperidine inhibitors of Janus kinase 3